{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:43Z","timestamp":1707524083209},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,20]]},"DOI":"10.7759\/cureus.9301","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T19:44:45Z","timestamp":1595274285000},"source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic Bilateral Salpingo-oophorectomy in BRCA2 Mutation with Incidental Finding of Serous Tubal Intraepithelial Carcinoma (STIC) and Subsequent Diagnosis of Primary Peritoneal Carcinoma (PPC): A Case Report and Review of Current Literature"],"prefix":"10.7759","author":[{"given":"Konstantinos","family":"Palaiologos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ellaboudy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Karan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arabinda","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","author":"Wooster R","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, et al.. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995, 789. 10.1038\/378789a0","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker KB","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, et al.. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017, 317:2402-2416. 10.1001\/jama.2017.7112","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1503523","article-title":"The role of risk-reducing surgery in hereditary breast and ovarian cancer","volume":"374","author":"Hartmann LC","year":"2016","unstructured":"Hartmann LC, Lindor NM. The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med. 2016, 374:454-468. 10.1056\/NEJMra1503523","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell CB","year":"2011","unstructured":"Powell CB, Chen LM, McLennan J, et al.. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer. 2011, 21:846-851. 10.1097\/IGC.0b013e31821bc7e3","journal-title":"Int J Gynecol Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10020057","article-title":"Recommendations and choices for BRCA mutation carriers at risk for ovarian cancer: a complicated decision","volume":"10","author":"Lewis KE","year":"2018","unstructured":"Lewis KE, Lu KH, Klimczak AM, Mok SC. Recommendations and choices for BRCA mutation carriers at risk for ovarian cancer: a complicated decision. Cancers. 2018, 10:57. 10.3390\/cancers10020057","journal-title":"Cancers"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high\u2010grade serous carcinomas","volume":"19","author":"Salvador S","year":"2009","unstructured":"Salvador S, Gilks B, Kobel M, Huntsman D, Rosen B, Miller D. The fallopian tube: primary site of most pelvic high\u2010grade serous carcinomas. Int J Gynecol Cancer. 2009, 19:58-64. 10.1111\/IGC.0b013e318199009c","journal-title":"Int J Gynecol Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson JW","year":"2008","unstructured":"Carlson JW, Miron A, Jarboe EA, et al.. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol. 2008, 26:4160-4165. 10.1200\/JCO.2008.16.4814","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-15-0072","article-title":"The fallopian tube: from back stage to center stage","volume":"8","author":"Greene MH","year":"2015","unstructured":"Greene MH, Mai PL. The fallopian tube: from back stage to center stage. Cancer Prev Res. 2015, 8:339-41. 10.1158\/1940-6207.CAPR-15-0072","journal-title":"Cancer Prev Res"},{"key":"ref9","unstructured":"National Comprehensive Cancer Network Guidelines, version 3 \u2014 genetic\/familial high-risk assessment. breast and ovarian. (2019). Accessed: June 9, 2020: https:\/\/www2.tri-kobe.org\/nccn\/guideline\/gynecological\/english\/genetic_familial.pdf."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin CG","year":"2010","unstructured":"Przybycin CG, Kurman RJ, Ronnett BM, Shih IM, Vang R. Are all pelvic (nonuterine) serous carcinomas of tubal origin?. Am J Surg Pathol. 2010, 34:1407-1416. 10.1097\/PAS.0b013e3181ef7b16","journal-title":"Am J Surg Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan MJ","year":"2007","unstructured":"Callahan MJ, Crum CP, Medeiros F, et al.. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007, 25:3985-3990. 10.1200\/JCO.2007.12.2622","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch A","year":"2006","unstructured":"Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 2006, 100:58-64. 10.1016\/j.ygyno.2005.06.065","journal-title":"Gynecol Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger DW","year":"2007","unstructured":"Kindelberger DW, Lee Y, Miron A, et al.. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007, 31:161-169. 10.1097\/01.pas.0000213335.40358.47","journal-title":"Am J Surg Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e31826a629b","article-title":"Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas","volume":"32","author":"Horn LC","year":"2013","unstructured":"Horn LC, Kafkova S, Leonhardt K, Kellner C, Einenkel J. Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas. Int J Gynecol Pathol. 2013, 32:339-344. 10.1097\/PGP.0b013e31826a629b","journal-title":"Int J Gynecol Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases","volume":"31","author":"Tang S","year":"2012","unstructured":"Tang S, Onuma K, Deb P, Wang E, Lytwyn A, Sur M, Daya D. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases. Int J Gynecol Pathol. 2012, 31:103-110. 10.1097\/PGP.0b013e31822ea955","journal-title":"Int J Gynecol Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.04.015","article-title":"Frequency of \u201cincidental\u201d serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: a six-year study","volume":"146","author":"Meserve EEK","year":"2017","unstructured":"Meserve EEK, Mirkovic J, Conner JR, et al.. Frequency of \u201cincidental\u201d serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: a six-year study. Gynecol Oncol. 2017, 146:69-73. 10.1016\/j.ygyno.2017.04.015","journal-title":"Gynecol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek JM","year":"2001","unstructured":"Piek JM, van Diest PJ, Zweemer RP, et al.. Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol. 2001, 195:451-456. 10.1002\/path.1000","journal-title":"J Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum CP","year":"2007","unstructured":"Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 2007, 5:35-44. 10.3121\/cmr.2007.702","journal-title":"Clin Med Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman RJ","year":"2016","unstructured":"Kurman RJ, Shih IM. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol. 2016, 186:733-747. 10.1016\/j.ajpath.2015.11.011","journal-title":"Am J Pathol"},{"key":"ref20","unstructured":"NICE Full Clinical Guideline CG164. familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. (2013). Accessed: June 9, 2020: https:\/\/www.nice.org.uk\/guidance\/cg164\/evidence\/full-guideline-pdf-190130941."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/36123-prophylactic-bilateral-salpingo-oophorectomy-in-brca2-mutation-with-incidental-finding-of-serous-tubal-intraepithelial-carcinoma-stic-and-subsequent-diagnosis-of-primary-peritoneal-carcinoma-ppc-a-case-report-and-review-of-current-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:09Z","timestamp":1707506889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/36123-prophylactic-bilateral-salpingo-oophorectomy-in-brca2-mutation-with-incidental-finding-of-serous-tubal-intraepithelial-carcinoma-stic-and-subsequent-diagnosis-of-primary-peritoneal-carcinoma-ppc-a-case-report-and-review-of-current-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.9301","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,20]]}}}